Chuck Oehler -
Primorigen Biosciences LLC

>> Next Bio

Chuck Oehler is co-founder of Primorigen Biosciences LLS and is Chairman and President.  He is also President of The Oehler Group, a high technology consulting firm that has assisted start-ups to Fortune 500 firms in raising ~$30 million and developing several lucrative business relationships. Mr. Oehler previously served as Vice President for Promega Corporation, a world-leading biotechnology research products firm, where he founded a multi-million dollar, revenue-generating research funding program, and led Promega's business and corporate development programs. He served in chief executive roles at two other organizations, doubling the size of one and eliminating inherited debt at both. He also served as elected President and consulting Executive Director of the Wisconsin Biotechnology Association, building it from 18 to over 100 corporate members while establishing a two-year financial reserve and founding the successful WBA Midwest Regional Biotechnology Conference. In 2004, he co-founded and currently serves as Chairman and President of NuPotential LLC, a biotechnology firm focused on a proprietary cell reprogramming platform for human cell therapy applications that has won nearly $1M. in NIH funding support. In 2005, he co-founded and current serves and Chairman and President of Primorigen Biosciences LLC, another biotechnology firm specializing in commercialization of protein detection and and cell therapy research technologies. Mr. Oehler raised multi-million dollar investments for each company from venture capital firms and insititutional and angel sources of capital. His many industry leadership roles have included service with Governor Thompson's Council on Biotechnology, the UW Medical School Biotechnology Master's Degree Program Board, the first BIO National Grassroots meeting, the 2004 Great Lakes Biomedical Conference, the Dane County Executive's Economic Strategies Group, Aberdean's Board of Advisors and others.